Share

Andy Bhattacharjee

PH.D.

Senior Investigator

Brigham and Women’s Hospital

Andy Bhattacharjee, PhD joined the Department of Pediatrics faculty in 2023 to help lead an initiative on the development of an in-house clinical perinatal genomics laboratory services that will aim to remove arriers for both OB/MFM and Neonatology physicians to utilize genomic diagnostic testing on appropriate patients, at low cost and with rapid turn around time, and to act as a resource to both our clinical and research faculty as they learn to integrate genomic information into precision neonatal care.

Dr. Bhattacharjee obtained a Master’s degree in Genetics at University of Saskatchewan and a PhD in Molecular Biology at the University of Minnesota. He previously trained at Harvard as a post-doctoral fellow in the Pathology Department at DFCI and the Whitehead Institute at MIT. Dr. Bhattacharjee joined BWH after spending 20 years in industry. He worked to develop targeted Next Generation Sequencing and Exome Sequencing at Agilent, and then set up three CLIA certified clinical Next Generation equencing laboratories focused on genomic sequencing of newborns : as the founder and CEO of Parabase Genomics, the Executive Vice President of Lab services at Babies, Inc. and the Executive and Laboratory Director of NCMG/Neuberg Diagnostics. Most recently, he was Vice President of Healthcare Genomics at Fabric Genomics, a company that has developed AI software for rapid interpretation of clinical genome sequences. Dr. Bhattacharjee has been a passionate innovator in bringing genomic information to the care of newborns by paving the way for NGS to be performed from Dried Blood Spots (DBS), a newborn screening collection standard. He has collaborated with Director of Newborn Genomics Dr. Richard Parad on multiple publications over the past 14 years, and together they are working to build the infrastructure to make genomic testing available and accessible in the electronic medical record, and to help teach our clinical and trainee staff how and when to best use this information.

Andy Bhattacharjee

PH.D.

Senior Investigator

Brigham and Women’s Hospital

Andy Bhattacharjee, PhD joined the Department of Pediatrics faculty in 2023 to help lead an initiative on the development of an in-house clinical perinatal genomics laboratory services that will aim to remove arriers for both OB/MFM and Neonatology physicians to utilize genomic diagnostic testing on appropriate patients, at low cost and with rapid turn around time, and to act as a resource to both our clinical and research faculty as they learn to integrate genomic information into precision neonatal care.

Dr. Bhattacharjee obtained a Master’s degree in Genetics at University of Saskatchewan and a PhD in Molecular Biology at the University of Minnesota. He previously trained at Harvard as a post-doctoral fellow in the Pathology Department at DFCI and the Whitehead Institute at MIT. Dr. Bhattacharjee joined BWH after spending 20 years in industry. He worked to develop targeted Next Generation Sequencing and Exome Sequencing at Agilent, and then set up three CLIA certified clinical Next Generation equencing laboratories focused on genomic sequencing of newborns : as the founder and CEO of Parabase Genomics, the Executive Vice President of Lab services at Babies, Inc. and the Executive and Laboratory Director of NCMG/Neuberg Diagnostics. Most recently, he was Vice President of Healthcare Genomics at Fabric Genomics, a company that has developed AI software for rapid interpretation of clinical genome sequences. Dr. Bhattacharjee has been a passionate innovator in bringing genomic information to the care of newborns by paving the way for NGS to be performed from Dried Blood Spots (DBS), a newborn screening collection standard. He has collaborated with Director of Newborn Genomics Dr. Richard Parad on multiple publications over the past 14 years, and together they are working to build the infrastructure to make genomic testing available and accessible in the electronic medical record, and to help teach our clinical and trainee staff how and when to best use this information.